GSI 7985 (Harvoni ledipasvir 90 mg / sofosbuvir 400 mg)
Generic Name: ledipasvir/sofosbuvir
Pill imprint GSI 7985 has been identified as Harvoni ledipasvir 90 mg / sofosbuvir 400 mg.
Harvoni is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 90 mg / sofosbuvir 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- GSI 7985
- ledipasvir 90 mg / sofosbuvir 400 mg
- Prescription only
- Drug Class:
- Antiviral combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Gilead Sciences, Inc.
More about Harvoni (ledipasvir / sofosbuvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 288 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.